Nuvo Pharmaceuticals Inc NRIFF

Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Market cap only 5.3M

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Oct 31, 2019 10:46am

134 Views

Post# 30291744

RE:RE:Market cap only 5.3M

correction: enterprise value = $148.2 million. The $126 million debt shown on the balance sheet is a carrying value. The principal o/s is $161.7 million.

lscfa wrote: But enterprise value = $112 million.

debt... $126 mil.
cash...$18 mil.
mkt cap...$4.5 mil.

midard wrote: · Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date ·
· Third Quarter Adjusted EBITDA - $7.8 million and $18.7 million year-to-date ·
· Third Quarter Gross Profit - $11.3 million and $30.0 million year-to date ·